Aster DM Healthcare Q4 profit jumps 80% to ₹153.6 crore; revenue up 18%

Aster DM Healthcare Ltd on Thursday reported an 80 per cent rise in consolidated net profit to ₹153.58 crore in the fourth quarter ended March 31, 2026.

The company had posted a consolidated net profit of ₹85.54 crore in the same period of the preceding year, Aster DM Healthcare Ltd said in a regulatory filing.

Consolidated revenue from continuing operations in the fourth quarter stood at ₹1,182.38 crore against ₹1,000.34 crore in the year-ago period, it added.

Its total expenses in the quarter under review were higher at ₹1,047.03 crore compared to ₹904.65 crore in the year-ago period, the company said.

For FY26, the company said consolidated net profit was ₹427.10 crore.

It was ₹5,407.89 crore in FY25, boosted by a profit after tax from discontinued operations at ₹5,071.2 crore, the filing said.

Its consolidated revenue from continuing operations in FY26 stood at ₹4,643.22 crore compared to ₹4,138.46 crore in FY25, the company said.

Commenting on the performance, Aster DM Healthcare founder and Chairman Azad Moopen said it reflects consistent execution, with margins improvement driven by "operating leverage and disciplined cost management".

On the merger of Aster DM Healthcare and Quality Care India Ltd (QCIL), in partnership with Blackstone, he said it "is progressing towards completion in Q1 FY 2026-27".

"The combined entity will have a capacity of over 10,623 beds across 28 cities, with an additional pipeline of around 4,445 beds, providing clear visibility to exceed 15,500 beds in the near term. This positions the platform to become one of the top three healthcare providers in India," Moopen said.

(Except for the headline, Fortune India has not edited the content of this PTI report.)